Tag: Viz.ai
New clinical data support Viz.ai solution for improved pulmonary embolism detection...
Viz.ai has announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai's PE...
Viz.ai to expedite patient enrolment in NIH-funded PE-TRACT clinical trial
Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal...
Viz.ai receives FDA 510(k) clearance for automated RV/LV analysis algorithm
Viz.ai recently announced it has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ventricle (RV)/left ventricle (LV) ratio algorithm,...
Viz.ai launches two new AI-powered modules for pulmonary embolism and aortic...
Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...
Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...
Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease.
Avicenna.AI’s US...